IL-17


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2021
Historique:
received: 14 07 2021
accepted: 02 09 2021
entrez: 15 10 2021
pubmed: 16 10 2021
medline: 8 1 2022
Statut: epublish

Résumé

Acne is a multifactorial disease driven by physiological changes occurring during puberty in the pilosebaceous unit (PSU) that leads to sebum overproduction and a dysbiosis involving notably

Identifiants

pubmed: 34650562
doi: 10.3389/fimmu.2021.740540
pmc: PMC8506309
doi:

Substances chimiques

Antigens, CD 0
Antigens, Differentiation, T-Lymphocyte 0
CD69 antigen 0
Interleukin-17 0
Lectins, C-Type 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

740540

Informations de copyright

Copyright © 2021 Eliasse, Leveque, Garidou, Battut, McKenzie, Nocera, Redoules and Espinosa.

Déclaration de conflit d'intérêts

DR, TN, and LG are employees of Pierre Fabre Dermo-Cosmétique (PFDC). The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Clin Dermatol. 2004 Sep-Oct;22(5):367-74
pubmed: 15556720
J Invest Dermatol. 2015 Jan;135(1):110-118
pubmed: 25010142
Nat Rev Immunol. 2019 Jan;19(1):19-30
pubmed: 30429578
Exp Dermatol. 2020 Mar;29(3):273-277
pubmed: 30379356
J Exp Med. 2007 Aug 6;204(8):1849-61
pubmed: 17635957
Nat Rev Rheumatol. 2013 Jun;9(6):375-9
pubmed: 23229447
J Exp Med. 2014 Jan 13;211(1):89-104
pubmed: 24395888
Blood. 2009 Dec 3;114(24):4979-88
pubmed: 19805617
Immunity. 2012 Dec 14;37(6):1091-103
pubmed: 23123063
Nat Rev Dis Primers. 2015 Sep 17;1:15029
pubmed: 27189872
Dermatology. 2015;231(2):105-11
pubmed: 26113292
Sci Transl Med. 2015 Mar 18;7(279):279ra39
pubmed: 25787765
J Clin Invest. 2007 Sep;117(9):2517-25
pubmed: 17786242
Sci Immunol. 2019 Jul 5;4(37):
pubmed: 31278120
Front Cell Neurosci. 2019 Sep 18;13:422
pubmed: 31619965
J Immunol. 2010 Apr 1;184(7):3336-40
pubmed: 20200272
Nat Rev Immunol. 2017 Sep;17(9):535-544
pubmed: 28555673
J Allergy Clin Immunol. 2015 Mar;135(3):626-35
pubmed: 25528359
Cell Rep. 2017 Sep 19;20(12):2921-2934
pubmed: 28930685
Eur J Immunol. 2003 Feb;33(2):474-82
pubmed: 12645946
Cytometry A. 2013 Jun;83(6):530-2
pubmed: 23504907
Eur J Immunol. 2010 Aug;40(8):2174-81
pubmed: 20486123
J Am Acad Dermatol. 2008 Apr;58(4):603-8
pubmed: 18249468
PLoS One. 2014 Aug 25;9(8):e105238
pubmed: 25153527
Immunity. 2013 May 23;38(5):970-83
pubmed: 23706669
Nat Rev Immunol. 2016 May 27;16(6):353-66
pubmed: 27231051
Nat Immunol. 2014 Nov;15(11):1064-9
pubmed: 25240383
J Allergy Clin Immunol. 2018 Aug;142(2):647-662
pubmed: 29128674
Nat Rev Immunol. 2016 Feb;16(2):79-89
pubmed: 26688350
J Invest Dermatol. 2003 Jul;121(1):20-7
pubmed: 12839559
J Allergy Clin Immunol. 2019 Jul;144(1):330-333.e6
pubmed: 30928651
J Immunol. 2015 Mar 1;194(5):2059-63
pubmed: 25624457
Nat Commun. 2016 May 10;7:11514
pubmed: 27160938
Br J Dermatol. 1988 May;118(5):651-9
pubmed: 2969256
Andrologia. 2016 Aug;48(6):617-25
pubmed: 26420243
J Allergy Clin Immunol. 2017 Apr;139(4):1205-1216.e6
pubmed: 27746235
J Immunol. 2011 Jul 1;187(1):490-500
pubmed: 21606249
Cell. 2014 Nov 6;159(4):814-28
pubmed: 25417158
Br J Dermatol. 2017 Nov;177(5):1458-1460
pubmed: 28144966
Immunity. 2016 Aug 16;45(2):442-56
pubmed: 27521270
J Cosmet Dermatol. 2019 Dec;18(6):1975-1979
pubmed: 30964235
Nat Rev Rheumatol. 2010 May;6(5):243
pubmed: 20440895
Exp Dermatol. 1998 Aug;7(4):191-7
pubmed: 9758417
J Allergy Clin Immunol. 2015 Aug;136(2):351-9.e1
pubmed: 25792465
Immunity. 2013 Jan 24;38(1):187-97
pubmed: 23260195
BMC Genomics. 2006 Aug 16;7:210
pubmed: 16911805
J Exp Med. 2009 Mar 16;206(3):525-34
pubmed: 19273624
Int J Mol Sci. 2021 Apr 27;22(9):
pubmed: 33925601
Theranostics. 2020 Aug 29;10(23):10743-10768
pubmed: 32929378
PLoS One. 2014 Sep 08;9(9):e106834
pubmed: 25197971
Trends Immunol. 2017 Feb;38(2):94-103
pubmed: 27939451
J Invest Dermatol. 2014 Feb;134(2):366-373
pubmed: 23924903
Nat Immunol. 2013 Dec;14(12):1294-301
pubmed: 24162776
J Invest Dermatol. 2014 May;134(5):1276-1284
pubmed: 24317395
Immunity. 2017 Mar 21;46(3):504-515
pubmed: 28329707
Immunity. 2019 Apr 16;50(4):892-906
pubmed: 30995505
J Allergy Clin Immunol. 2013 May;131(5):1400-7.e11
pubmed: 23518141
J Invest Dermatol. 2003 Nov;121(5):1226-8
pubmed: 14708633
J Exp Med. 2008 Aug 4;205(8):1903-16
pubmed: 18663128
Immunology. 2018 May;154(1):3-20
pubmed: 29313948

Auteurs

Yoan Eliasse (Y)

Inserm, U1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Toulouse, France.
Université de Toulouse, Université Paul Sabatier, Toulouse, France.

Edouard Leveque (E)

Inserm, U1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Toulouse, France.
Université de Toulouse, Université Paul Sabatier, Toulouse, France.

Lucile Garidou (L)

Department of Pharmacology, Pierre Fabre Dermo-Cosmétique, Toulouse, France.

Louise Battut (L)

Inserm, U1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Toulouse, France.
Université de Toulouse, Université Paul Sabatier, Toulouse, France.

Brienne McKenzie (B)

Inserm, U1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Toulouse, France.
Université de Toulouse, Université Paul Sabatier, Toulouse, France.

Thérèse Nocera (T)

Clinical Evaluation Center, Pierre Fabre Dermo-Cosmétique, Toulouse, France.
Dermatology Department, University Hospital Larrey, Toulouse, France.

Daniel Redoules (D)

Department of Pharmacology, Pierre Fabre Dermo-Cosmétique, Toulouse, France.

Eric Espinosa (E)

Inserm, U1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Toulouse, France.
Université de Toulouse, Université Paul Sabatier, Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH